.
MergerLinks Header Logo

New Deal


Announced

Completed

Phoenix-backed Sygnature Discovery completed the acquisition of XenoGesis.

Synopsis

Phoenix Equity Partners-backed Sygnature Discovery, a drug discovery company, completed the acquisition of XenoGesis, the UK’s largest independent laboratory-based CRO. Financial terms were not disclosed. "This acquisition effectively doubles the size of our DMPK department (established in 2015), broadening our discovery and development expertise, complementing our existing service-offering and adding new skills and capabilities," Sygnature Discovery.

Show Details & Financials

Market Context

Sort

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US